Suitable Antibacterial Substances for the Treatment of Urinary Tract Infections
Journal:
Anti-Infective Agents in Medicinal Chemistry
Volume:
5
Page:
309-329
Author(s):
Florian M.E Wagenlehner and Kurt G. Naber
Antineovascular Agents in the Treatment of Eye Diseases
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
2645-2660
Author(s):
Wolfram Eichler, Yousef Yafai, Peter Wiedemann and Dorte Fengler
Painful Peripheral Neuropathies
Journal:
Current Neuropharmacology
Volume:
4
Page:
175-181
Author(s):
P. Marchettini, M. Lacerenza, E. Mauri and C. Marangoni
Homocysteine and Folate Therapy in Dialysis Patients
Journal:
Letters in Drug Design & Discovery
Volume:
3
Page:
351-355
Author(s):
Marco Righetti
Dyslipidaemia, Hypercoagulability and the Metabolic Syndrome
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
175-183
Author(s):
Anna I. Kakafika, Evagelos N. Liberopoulos, Asterios Karagiannis, Vasilios G. Athyros and Dimitri P. Mikhailidis
Definitions of Metabolic Syndrome: Where are We Now?
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
185-197
Author(s):
Stella S. Daskalopoulou, Vassilis G. Athyros, Genovefa D. Kolovou, Katherine K. Anagnostopoulou and Dimitri P. Mikhailidis
Role of Oxidative Stress in Development of Cardiovascular Complications in Diabetes Mellitus
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
215-227
Author(s):
Mohamed A. Haidara, Hanaa Z. Yassin, Moshira Rateb, Hania Ammar and Mahmoud A. Zorkani
Statins for Diabetic Cardiovascular Complications
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
245-251
Author(s):
Sora Ludwig and Garry X. Shen
Drug Therapies in the Secondary Prevention of Cardiovascular Diseases:Successes, Shortcomings and Future Directions
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
253-268
Author(s):
Eva Lonn and Jasmine Grewal
Facing Up the ROS Labyrinth - Where To Go?
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
277-289
Author(s):
Armando Rojas, Hector Figueroa, Miguel A. Morales and Lamberto Re